Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic v

[Guest guest]

Surveillance programme for hepatocellular carcinoma improves the survival of

patients with chronic viral hepatitis

Authors: Wong, Grace Lai-Hung1; Wong, Wai-Sun1; Tan, Guang-Ming1; Ip,

Ka-Ian1; Lai, Wing-Kwan1; Li, Yuk-Wah1; Mak, Mercedes Shun-Chi1; Lai,

Bo-San2; Sung, ph Jao-Yiu1; Chan, Henry Lik-Yuen1

Source: Liver International, Volume 28, Number 1, January 2008 , pp. 79-87(9)

Publisher: Blackwell Publishing

Abstract:

Background:

The survival benefit of surveillance for hepatocellular carcinoma (HCC) is

controversial. Aim:

We aimed to examine the survival benefit of HCC surveillance in chronic viral

hepatitis. Methods:

Survivals of HCC patients related to chronic viral hepatitis from the Hepatology

Clinic (surveillance group) were compared with those referred from other

hospitals/clinics (no-surveillance group). Lead-time and length-time biases were

adjusted based on tumour volume doubling times. Results:

Among 579 patients (91% hepatitis , 472 (82%) patients had HCC and 79 (17%) of

these patients were referred from the surveillance programme. HCC was smaller

(4.2 vs. 7.7 cm; P

_________________________________________________________________

Share life as it happens with the new Windows Live.

http://www.windowslive.com/share.html?ocid=TXT_TAGHM_Wave2_sharelife_122007

[Guest guest]

Surveillance programme for hepatocellular carcinoma improves the survival of

patients with chronic viral hepatitis

Authors: Wong, Grace Lai-Hung1; Wong, Wai-Sun1; Tan, Guang-Ming1; Ip,

Ka-Ian1; Lai, Wing-Kwan1; Li, Yuk-Wah1; Mak, Mercedes Shun-Chi1; Lai,

Bo-San2; Sung, ph Jao-Yiu1; Chan, Henry Lik-Yuen1

Source: Liver International, Volume 28, Number 1, January 2008 , pp. 79-87(9)

Publisher: Blackwell Publishing

Abstract:

Background:

The survival benefit of surveillance for hepatocellular carcinoma (HCC) is

controversial. Aim:

We aimed to examine the survival benefit of HCC surveillance in chronic viral

hepatitis. Methods:

Survivals of HCC patients related to chronic viral hepatitis from the Hepatology

Clinic (surveillance group) were compared with those referred from other

hospitals/clinics (no-surveillance group). Lead-time and length-time biases were

adjusted based on tumour volume doubling times. Results:

Among 579 patients (91% hepatitis , 472 (82%) patients had HCC and 79 (17%) of

these patients were referred from the surveillance programme. HCC was smaller

(4.2 vs. 7.7 cm; P

_________________________________________________________________

Share life as it happens with the new Windows Live.

http://www.windowslive.com/share.html?ocid=TXT_TAGHM_Wave2_sharelife_122007